Journal of Microbiology and Biotechnology

  • 제33권11호
  • /
  • Pages.1484-1494
  • /
  • 2023
  • /
  • 1017-7825(pISSN)
  • /
  • 1738-8872(eISSN)
한국미생물·생명공학회 (The Korean Society for Microbiology and Biotechnology)
권호 표지
DOI QR코드

DOI QR Code

Protective Effects of a Mixed Medicinal Herb Extract (NUC1) on Collagenase-Induced Osteoarthritis in Rabbits

  • Sung-Gyu Lee (Department of Medical Laboratory Science, College of Health Science, Dankook University) ;
  • Hyun Kang (Department of Medical Laboratory Science, College of Health Science, Dankook University)
  • 투고 : 2023.03.29
  • 심사 : 2023.07.12
  • 발행 : 2023.11.28
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

NUC1 (Nutraceutical compound 1) is an ethanol extract composed of a formulation based on medicinal herbs traditionally used for the treatment of arthritis in Korea and China. This study investigated the therapeutic effects of NUC1 on osteoarthritis (OA). The protective effect of NUC1 on OA was tested in a rabbit model of collagenase-induced arthritis (CIA) for 4 weeks. Results were compared among four groups (n = 9 per group): the normal group (untreated), the CIA group (vehicle control), the NUC1 group (CIA rabbits treated with 200 mg/kg NUC1), and the JOINS group (positive control, CIA rabbits treated with 200 mg/kg JOINS tablet). NUC1 significantly inhibited NO production (p < 0.05 at 125 ㎍/ml, p < 0.01 at 250 ㎍/ml, and p < 0.001 at 500 ㎍/ml) and iNOS expression in macrophages, in a concentration-dependent manner. NUC1 also inhibited the release and protein expression of MMP-1, 3, and 13, in TNF-α-induced chondrosarcoma cells in a concentration-dependent manner. In vivo, the MMP-1 and MMP-3 levels in synovial fluids were significantly (p < 0.05) lower in NUC1 group (77.50 ± 20.56 and 22.50 ± 7.39 pg/ml, respectively) than in the CIA group (148.33 ± 68.58 and 77.50 ± 20.46 pg/ml, respectively). Also, in histopathological, NUC1 ameliorated articular cartilage damage in OA by increasing the abundance of chondrocytes and proteoglycan in the articular cartilage. Thus, NUC1 showed promise as a potential therapeutic agent, and it can be generalized to a broader study population in different OA animal models.

키워드

과제정보

The present study was supported by the research fund of Dankook University in 2022.

참고문헌

  1. Orhan C, Juturu V, Sahin E, Tuzcu M, Ozercan IH, Durmus AS, et al. 2021. Undenatured type II collagen ameliorates inflammatory responses and articular cartilage damage in the rat model of osteoarthritis. Front. Vet. Sci. 8: 617789.
  2. Sifre V, Soler C, Segarra S, Redondo JI, Domenech L, Ten-Esteve A, et al. 2022. Improved joint health following oral administration of glycosaminoglycans with native type ii collagen in a rabbit model of osteoarthritis. Animals (Basel). 12. doi: 10.3390/ani12111401.
  3. Goldring MB, Goldring SR. 2010. Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Ann. NY Acda. Sci. 1192: 230-237.
  4. Kraus VB. 1997. Pathogenesis and treatment of osteoarthritis. Med. Clin. North Am. 81: 85-112.
  5. Dean DD, Martel-Pelletier J, Pelletier JP, Howell DS, Woessner JFJ.1989. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritis cartilage. J. Clin. Investig. 84: 678-685.
  6. Bijlsma JW, Berenbaum F, Lafeber FP. 2011. Osteoarthritis: an update with relevance for clinical practice. Lancet 377: 2115-2126.
  7. Hawkey C, Laine L, Simon T, Beaulieu A, Maldonado-Cocco J, Acevedo E, et al. 2000. The rofecoxib osteoarthritis endoscopy multinational study group. Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: a randomized, double-blind, placebo controlled trial. Arthritis Rheum. 43: 370-377.
  8. Sim WH and Seo BI. 2018. A study on the effect comparative of Acanthopanax stem bark (ASB) and Acanthopanax root bark (ARB) on the monosodium iodoacetate (MIA)-induced osteoarthritis rats. Kor. J. Herbol. 33: 53-66.
  9. Lee BK, Lee YC, Lee JC. 2010. Inhibitory effect of a decoction of Eucommiae ulmides Oliver and Dipsacus asperoides CY Cheng et TMAi on collagen II-induced arthritis mice. Kor. J. Herbol. 25: 55-63.
  10. Lee JS, Kim IS, Kim JH, Kim JS, Kim DH, Yun CY. 2008. Suppressive effects of Houttuynia cordata Thunb (Saururaceae) extract on Th2 immune response. J. Ethnopharmacol. 117: 34-40.
  11. Jo HK, Kim DS, Kim JY, Park YM, Shin DY, Lee HY, et al. 2020. Anti-inflammatory effect of herbal complex HP-04 on degenerative osteoarthritis. Kor. J. Pharmacogn. 51: 122-130.
  12. Lee SG, Jeong HJ, Lee EJ, Kim JB, Choi SW. 2011. Antioxidant and anti-inflammatory activities of ethanol extracts from medicinal herb mixtures. Korea J. Food Sci. Technol. 43: 200-205.
  13. Lee S. (1590 A.D.). 1978. Bon Cho Gang Mok [Compendium of material medica]. ChungKuK ChungEuiHak. Peking.
  14. Lee SG, Lee EJ, Park WD, Kim JB, Kim EO, Choi SW. 2012. Anti-inflammatory and anti-osteoarthritis effects of fermented Achyranthes japonica Nakai. J. Ethnopharmacol. 142: 634-641.
  15. Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65: 55-63.
  16. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. 1982. Analysis of nitrate, nitrite and (15N) nitrate in biological fluids. Anal. Biochem. 126: 131-138.
  17. Gogly B, Groult N, Hornebeck W, Godeau G, Pellat B. 1998. Collagen zymography as a sensitive and specific technique for the determination of subpicogram levels of interstitial collagenase. Anal. Biochem. 255: 211-216.
  18. Kikuchi T, Sakuta T, Uamaguchi T. 1998. Intra-articular injection of collagenase experimental osteoarthritis in mature rabbits. Osteoarthr. Cartil. 6: 177-186.
  19. Pritzker KP, Gay S, Jimenez SA, Ostergaard K, Pelletier JP, Revell PA, et al. 2006. Osteoarthritis cartilage histopathology: grading and staging Osteoarthr. Cartil. 14: 13-29.
  20. El-Baz FK, Salama AAA, Hussein RA. 2020. Dunaliella salina microalgae oppose thioacetamide-induced hepatic fibrosis in rats. Toxicol. Rep. 7: 36-45.
  21. Troeberg L, Nagase H. 2011. Proteases involved in cartilage matrix degradation in osteoarthritis. Biochim. Biophys. Acta 1824: 133-145.
  22. Felson DT. 2009. Developments in the clinical understanding of osteoarthritis. Arthritis Res. Ther. 11: 203.
  23. Martel-Pelletier J. 1998. Pathophysiology of osteoarthritis. Osteoarthr. Cartil. 6: 374-376.
  24. Benito MJ, Veale DJ, FitzGerald O, van den Berg W, Bresnihan B. 2005. Synovial tissue inflammation in early and late osteoarthritis. Ann. Rheum. Dis. 64: 1263-1267.
  25. Deng JS, Chiu CS, Huang SS, Shie PH, Lin TH, Huang GJ. 2011. Antioxidant, analgesic, and anti-inflammatory activities of the ethanol extracts of Taxillus liquidambaricola. J. Ethnopharmacol. 137: 1161-1171.
  26. Tchetcerikov I, Lohmander LS, Verzijl N, Huizinga TW, Tekoppele JM, Hanemaaijer R, et al. 2005. MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis. Ann. Rheum. Dis. 64: 694-698.
  27. Brennan FM, McInnes IB. 2008. Evidence that cytokines play a role in rheumatoid arthritis. J. Clin. Investig. 118: 3537-3545.
  28. Jeffery J. 1998. Interstitial collagenases. In Matrix Metalloproteinases: Parks WC, Mecham RP (eds.), pp. 15-38. Academic Press, San Diego, CA, USA.
  29. Visse R, Nagase H. 2003. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92: 827-839.
  30. Birkedal-Hansen H. Moore WG, Bodden MK. 1993. Matrix metalloproteinases: a review. Crit. Rev. Oral Biol. Med. 4: 197-250.
  31. Goldring MB. 2000. The role of the chondrocyte in osteoarthritis. Arthritis Rheum. 43: 1916-1926.
  32. Billinghurst RC, Dahlberg L, Ionescu M. 1997. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J. Clin. Investig. 99: 1534-1545.
  33. Neuhold LA, Killar L, Zhao W, Sung ML, Warner L, Kulik J, et al. 2001. Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. J. Clin. Investig. 107: 35-44.
  34. van den Berg WB. 2000. Pathophysiology of osteoarthritis. Joint Bone Spine 67: 555-556.
  35. Loeser RF, Goldring SR, Scanzello CR, Goldring MB. 2012. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum. 64: 1697-1707.
  36. Cunnane G, Fitzgerald O, Beeton C. 2001. Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinase 1 in rheumatoid arthritis. Arthritis Rheum. 44: 2263-2274.
  37. Gosset M, Pigenet A, Salvat C, Berenbaum F, Jacques CJ. 2010. Inhibition of matrix metalloproteinase-3 and -13 synthesis induced by IL-1beta in chondrocytes from mice lacking microsomal prostaglandin E synthase-1. J. Immunol. 185: 6244-6252.
  38. Li Y, Yang B, Baia JY, Xiaa S, Maoa M, Lia M, et al. 2019. The roles of synovial hyperplasia, angiogenesis and osteoclastogenesis in the protective effect of apigenin on collagen-induced arthritis. Int. Immunopharmacol. 73: 362-369.
  39. Hussain T, Tan B, Liu G, Oladele OA, Rahu N, Tossou MC. 2016. Health-promoting properties of Eucommia ulmoides: a review. Evid. Based Complement. Alternat. Med. 2016: 5202908.
  40. Choi JW, Huh K, Kim SH, Lee KT, Park HJ, Han YN. 2002. Antinociceptive and anti-rheumatoidal effects of Kalopanax pictus extract and its saponin components in experimental animals. J. Ethnopharmacol. 79: 199-204.
  41. Fikry EM, Gad AM, Eid AH, Arab HH. 2019. Caffeic acid and ellagic acid ameliorate adjuvant-induced arthritis in rats via targeting inflammatory signals, chitinase-3-like protein-1 and angiogenesis. Biomed. Pharmacother. 110: 878-886.
  42. Du K, Fang X, Li Z. 2021. Ferulic acid suppresses interleukin-1β-induced degeneration of chondrocytes isolated from patients with osteoarthritis through the SIRT1/AMPK/PGC-1α signaling pathway. Immun. Inflamm. Dis. 9: 710-720.
  43. Wang H, Yan Y, Pathak JL, Hong W, Zeng J, Qian D, et al. 2023. Quercetin prevents osteoarthritis progression possibly via regulation of local and systemic inflammatory cascades. J. Cell. Mol. Med. 27: 471-592.